BR0007428A - Composições com estabilidade aprimorada - Google Patents

Composições com estabilidade aprimorada

Info

Publication number
BR0007428A
BR0007428A BR0007428-4A BR0007428A BR0007428A BR 0007428 A BR0007428 A BR 0007428A BR 0007428 A BR0007428 A BR 0007428A BR 0007428 A BR0007428 A BR 0007428A
Authority
BR
Brazil
Prior art keywords
compositions
liquid
improved stability
pharmaceutical active
atomizers
Prior art date
Application number
BR0007428-4A
Other languages
English (en)
Inventor
Douglas Joseph Dobrozsi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0007428A publication Critical patent/BR0007428A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"COMPOSIçõES COM ESTABILIDADE APRIMORADA". A presente invenção pertence a composições com veiculação dos princípio ativo farmacêuticos aprimorada. Estas composições compreendem princípio ativo farmacêuticos em um solvente. Estas composições podem tomar a forma de elixires líquidos postos na boca e eventualmente ingeridos ou podem ser veiculadas através de pastilhas preenchidas com líquido, dispositivos de dosagem com a medida de líquido, atomizadores e cápsulas comestíveis que liberam líquido.
BR0007428-4A 1999-01-11 2000-01-10 Composições com estabilidade aprimorada BR0007428A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11537899P 1999-01-11 1999-01-11
US15653999P 1999-09-29 1999-09-29
PCT/US2000/000574 WO2000041692A2 (en) 1999-01-11 2000-01-10 Compositions having improved stability

Publications (1)

Publication Number Publication Date
BR0007428A true BR0007428A (pt) 2002-10-15

Family

ID=26813132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007428-4A BR0007428A (pt) 1999-01-11 2000-01-10 Composições com estabilidade aprimorada

Country Status (16)

Country Link
US (1) US20020086878A1 (pt)
EP (1) EP1143973A2 (pt)
JP (1) JP2002534462A (pt)
KR (1) KR20010093256A (pt)
CN (1) CN1346270A (pt)
AU (1) AU3344900A (pt)
BR (1) BR0007428A (pt)
CA (1) CA2360358A1 (pt)
CO (1) CO5430216A1 (pt)
CZ (1) CZ20012493A3 (pt)
HU (1) HUP0105279A3 (pt)
ID (1) ID30508A (pt)
NO (1) NO20013440L (pt)
PE (1) PE20001397A1 (pt)
TR (1) TR200101929T2 (pt)
WO (1) WO2000041692A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04007657A (es) 2002-02-08 2004-11-10 Procter & Gamble Sachet a prueba de ninos.
US20040028622A1 (en) * 2002-08-12 2004-02-12 Michael Gurin Multifunctional flavor systems and method of use
DK1575569T3 (da) 2002-12-13 2011-01-10 Durect Corp Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
US20070059417A1 (en) * 2005-09-15 2007-03-15 Moza Ashok K Cooling agents as flavor and saltiness enhancers
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
US11234897B2 (en) 2017-03-27 2022-02-01 DXM Pharmaceutical, Inc. Packaged multi-dose liquid dextromethorphan hydrobromide formulation
WO2018183203A1 (en) * 2017-03-27 2018-10-04 DXM Pharmaceutical, Inc. Packaged multi-dose liquid drug formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
CA2181241C (en) * 1994-01-24 2000-04-25 Dadi Jamshed Dhabhar Process for solubilizing difficultly soluble pharmaceutical actives
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids

Also Published As

Publication number Publication date
CZ20012493A3 (cs) 2001-11-14
HUP0105279A2 (hu) 2002-05-29
KR20010093256A (ko) 2001-10-27
HUP0105279A3 (en) 2003-05-28
ID30508A (id) 2001-12-13
NO20013440L (no) 2001-09-11
TR200101929T2 (tr) 2001-12-21
CO5430216A1 (es) 2004-06-01
EP1143973A2 (en) 2001-10-17
NO20013440D0 (no) 2001-07-11
CN1346270A (zh) 2002-04-24
AU3344900A (en) 2000-08-01
PE20001397A1 (es) 2000-12-21
JP2002534462A (ja) 2002-10-15
CA2360358A1 (en) 2000-07-20
WO2000041692A2 (en) 2000-07-20
US20020086878A1 (en) 2002-07-04
WO2000041692A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
BR0007445A (pt) Composições tendo fornecimento aperfeiçoado de ingredientes ativos
BR0007428A (pt) Composições com estabilidade aprimorada
BR0014441A (pt) Composições que apresentam estabilidade aperfeiçoada
ES2193726T3 (es) Formulaciones de aerosol medicinales.
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
SG147485A1 (en) Pharmaceutical compositions for prevention of overdose or abuse
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
DE69520492T2 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
BR9711585A (pt) Composição de microcápsula, com sabor mascarado, de um remédio solúvel em água, formulação farmacêutica para administrar um remédio, e, processo para disfarçar o sabor de um remédio.
NZ514248A (en) Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
BR0211198A (pt) Composições farmacêuticas e seu uso
BR0007473A (pt) Composições tendo estabilidade melhorada
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
RS50241B (sr) Mikrogranule nerastvorljive u želudačnim sokovima, postupak za njihovo dobijanje i farmaceutski preparati
PL348202A1 (en) Pharmaceutically active composition and dispensing device
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
BRPI0412010A (pt) sistema de distribuição de drogas tópicas
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
BRPI9914031B8 (pt) partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.